Hereditary Leiomyomatosis
1 clinical trials · Condition
◉ Watch Hereditary Leiomyomatosis
| Record | Firm | Date |
|---|---|---|
| Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma (NCT02495103) | National Cancer Institute (NCI) | 2015-08-26 |
Track Hereditary Leiomyomatosis automatically
Every clearance here is in the API, with alerts when new ones post.